Ionis stock investment
Web12 apr. 2024 · Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Misses Revenue Estimates. Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 65.09% and … Web9 nov. 2024 · As of September 30, 2024, Ionis had cash, cash equivalents and short-term investments of $2.0 billion, compared with $2.1 billion at December 31, 2024. Ionis' …
Ionis stock investment
Did you know?
Web2 dec. 2024 · Going by historical performance of IONS stock, we expected the stock to rebound over the next month or so. IONS stock rose from levels of $30 on October 18 to … Web11 apr. 2024 · En el último trimestre, Ionis Pharmaceuticals (NASDAQ: IONS) ha recibido las siguientes calificaciones por parte de los analistas: En los últimos 3 meses, 10 analistas le han asignado precios objetivo de 12 meses a Ionis Pharmaceuticals. La compañía tiene un precio objetivo promedio de 46,10 dólares, con un máximo de 67,00 dólares y un ...
WebJan-10-23 02:35PM. Ionis Pharmaceuticals (NASDAQ:IONS) shareholders have endured a 41% loss from investing in the stock three years ago. Simply Wall St. Jan-09-23 … Web9 jan. 2024 · NEW YORK and CARLSBAD, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc RPRX and Ionis Pharmaceuticals, Inc. IONS today announced that Royalty Pharma has acquired an interest in Ionis’ royalty in Biogen’s SPINRAZA® (nusinersen) and Novartis’ pelacarsen for up to $1.125 billion, including an upfront …
Web19 okt. 2024 · 10 stocks we like better than Ionis Pharmaceuticals When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the … Web12 apr. 2024 · Ionis Pharmaceuticals has a 1 year low of $31.46 and a 1 year high of $48.82. The stock has a market cap of $5.32 billion, a price-to-earnings ratio of -19.59 and a beta of 0.54. The company...
WebFind the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Web12 apr. 2024 · Ionis Pharmaceuticals has a 12-month low of $31.46 and a 12-month high of $48.82. The stock has a market cap of $5.32 billion, a price-to-earnings ratio of -19.59 and a beta of 0.54. The... michael becher pinnacleWeb8 mei 2013 · Isis Pharmaceuticals, Inc. 9,000,000 shares of common stock, par value $0.001 per share Underwriting Agreement from IONIS PHARMACEUTICALS INC filed with the ... Securities underwritten by it and distributed to investors were offered to investors exceeds the amount of any damages which such Underwriter has otherwise been … how to change age in shindo lifeWeb14 apr. 2024 · Stock Research; Market ... Fidelity Management & Research Co has recently announced that it has increased stake in Ionis Pharmaceuticals Inc. (NASDAQ:IONS) by 0.08%. After grabbing 21.31 million shares, the institutional investor is now in possession of 16360.0 shares of the Healthcare Company. The new investment brought the stake of ... michael bechtold lebanon paWebIonis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs. how to change age in battle netWeb1 dag geleden · Why Ionis Pharmaceuticals Inc’s (IONS) Stock Is Down 4.73% As of Thursday, March 23, Ionis Pharmaceuticals Inc’s IONS share price has dipped by … michael becht therapistWeb31 mrt. 2024 · Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) stock rose 3.8% last week, but insiders who sold US$1.5m worth of stock over the last year are probably in a more … michael becht orthodonticsWeb11 apr. 2024 · Conflict of interest Scott M. Damrauer receives research support (to the University of Pennsylvania) from RenalytixAI and personal fees from Caico Ibs, both outside the scope of the present work. SMD is also named as a co-inventor on a government-owned US Patent application related to the use of genetic risk prediction for venous … how to change age on outlook account